Results 7,481-7,500 of 20,758 for speaker:Alan Kelly
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: Obviously I understand everything that Mr. McCallion has said but there is a requirement to figure out with why things happened as they did and "institutional failure" is just too fluffy. I am not picking on anyone when I say that. We need to find out why things happened in the way they did and Mr. McCallion said that he would do that. He possibly cannot answer my question now but I am...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: If there is no figure, that is even more worrying.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: Yes, but there must be a figure. This country is not run on the basis of just doing things and worrying about the costs later. If there is no figure available today, that is even more worrying. I must stress that I am not criticising the Minister for the commitment he gave. In fact, had any of us been in his position at the time, we would probably have made the same decision. I do not...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: Where does this leave us?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: I do not know where to go with this. I have asked a pretty obvious question. I am not having a go at anyone. Perhaps the witnesses could write to the committee giving more information on the costs of the programme to date.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: Would that be fair?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: I do not want to be unfair. My next question is for the Department. The Minister has made a commitment that there will be two patient advocates on boards, which is only right and proper, particularly with regard to the board of the HSE which is being reinstated. That board should never have been abolished. In my view, we need to take a different approach to finding such people. We need...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: I thank the witnesses for their input which has been quite good.
- Written Answers — Department of Health: National Drugs Strategy Budget (8 Nov 2018)
Alan Kelly: 160. To ask the Minister for Health the process used to make a decision to increase or decrease an amount (details supplied); if this figure will increase for 2019; and his role in determining same. [46291/18]
- Written Answers — Department of Health: National Drugs Strategy Budget (8 Nov 2018)
Alan Kelly: 161. To ask the Minister for Health the process used to make a decision to increase or decrease an amount (details supplied); the provision for drug and alcohol task forces within this figure; if the figure for task forces within this heading will increase for 2019; and his role in determining same. [46292/18]
- Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)
Alan Kelly: I am not going to repeat what my colleagues have said because I agree with them. However, I would not necessarily agree with some of the amendments because of legal issues. The real issue is that this is not women-centric and the language is hurtful. It is not what the people who have spoken to me expect. Based on the themes raised in the discourse, I hope the Minister will find a...
- Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)
Alan Kelly: Yes.
- Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)
Alan Kelly: That is very clear.
- Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)
Alan Kelly: We could sit from 7 p.m. to 8 p.m.
- Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)
Alan Kelly: The amendments should be grouped thematically; it makes sense.
- Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)
Alan Kelly: They are all grouped.
- Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)
Alan Kelly: I also support the removal of the word "serious". Speaking to my amendment, my advice is that the word "avert" in section 10(1)(c) is too absolute in its meaning and it needs to be examined. That is why I have suggested, as has Deputy O'Reilly, that we put in "to avert or mitigate". I do not understand why that could not be allowed. We have looked at the measure in different ways and the...
- Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)
Alan Kelly: I will not be supporting the amendment. With all due respect, I cannot even see why it is being brought forward in the way it is. I would see the provision as a fundamental change and think it would change everything. I presume that in the advice the Minister has been given and the consultation he has had with medics he has been told that they would not see that they would be able to...
- Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)
Alan Kelly: That is enough for me.
- Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)
Alan Kelly: That clears up the matter.